BTSG Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
4.2B
+8.8%
3.9B
+7.2%
3.6B
+1.8%
3.6B
+6.5%
3.3B
Cost of Revenue
3.7B
+9.3%
3.4B
+7.9%
3.1B
-0.2%
3.1B
+6.7%
2.9B
Gross Profit
518.5M
+5.2%
492.7M
+2.2%
482.2M
+16.9%
412.5M
+5.2%
392.0M
Operating Expenses
358.1M
-1.2%
362.4M
+0.4%
360.8M
+18.5%
304.4M
+0.1%
304.2M
R&D
0
0
0
0
0
SG&A
358.1M
-1.2%
362.4M
+0.4%
360.8M
+18.5%
304.4M
+0.1%
304.2M
Operating Income
160.5M
+23.1%
130.4M
+7.4%
121.4M
+12.3%
108.1M
+23.1%
87.8M
EBITDA
198.9M
+15.7%
171.8M
+7.0%
160.5M
+8.7%
147.6M
+14.8%
128.6M
Net Income
100.3M
+19.1%
84.2M
-43.3%
148.6M
+92.2%
77.3M
+40.0%
55.2M
EPS (Basic)
$0.48
+17.1%
$0.41
-43.8%
$0.73
+92.1%
$0.38
+40.7%
$0.27
EPS (Diluted)
$0.45
+18.4%
$0.38
-43.3%
$0.67
+97.1%
$0.34
+30.8%
$0.26
Shares (Diluted)
220.2M
-0.0%
220.3M
-0.5%
221.3M
-3.7%
229.9M
+5.4%
218.0M
BrightSpring Health Services (BTSG) — Financials